European Alliance for Personalised Medicine

Their core work

The European Alliance for Personalised Medicine (EAPM) is a multi-stakeholder alliance based in Slovenia that advocates for and supports the integration of personalised and precision medicine into European healthcare systems. They contribute policy expertise, network coordination, and knowledge exchange across large-scale health data initiatives — from hematological cancer research to genomic infrastructure and digital health strategies. Their role in projects typically involves bridging the gap between research communities, policymakers, and healthcare professionals to ensure that precision medicine advances translate into practical healthcare improvements.

What they specialise in

How they've shifted over time

EAPM's early H2020 involvement (2017–2018) centred on disease-specific big data initiatives, particularly hematological cancers (HARMONY) and prostate cancer (PIONEER), with a focus on real-life patient data and evidence gaps. From 2019 onward, their work shifted decisively toward systemic and infrastructure-level topics: digital health governance, genomic data standards (B1MG), and the integration of precision medicine into healthcare systems at scale. This trajectory shows a move from contributing to disease-focused research consortia toward shaping the policy and data architecture that underpins all of personalised medicine.

EAPM is moving toward genomic data governance and digital health system design, making them a strong partner for future projects around European Health Data Space and cross-border genomic initiatives.

How they like to work

EAPM consistently operates as a participant rather than a coordinator, joining large, multi-partner consortia (152 unique partners across 5 projects). Their strength lies in connecting diverse communities — researchers, clinicians, policymakers — rather than leading technical work packages. This makes them a reliable network-building partner who brings convening power and policy access to any consortium they join.

With 152 unique consortium partners across 24 countries, EAPM has one of the broader partnership networks relative to their project count. Their reach is pan-European with no strong geographic clustering, reflecting their role as a cross-border alliance rather than a national entity.

What sets them apart

EAPM occupies a rare position as a non-governmental alliance that sits at the intersection of precision medicine research, health policy, and data governance — a combination few organisations can claim. While registered in Slovenia, their pan-European network of 152 partners across 24 countries gives them reach well beyond their national base. For consortium builders, EAPM brings political and policy connectivity that complements technical and clinical partners.

Highlights from their portfolio

• B1MG
  Directly supports the EU 1+ Million Genomes Declaration — a flagship genomic infrastructure initiative with implications for all future personalised medicine projects.
• HARMONY
  One of the largest big data platforms for hematological malignancies in Europe, representing EAPM's entry into disease-specific research at scale.
• DigitalHealthEurope
  A coordination and support action directly tied to the EU Digital Single Market strategy, positioning EAPM at the policy-practice interface of digital health.